European Journal of Pharmacology

Motor effects of lamotrigine in naive and dopamine-depleted mice
pp. 1-6(6)
Authors: Kaur S.; Starr M.

Alcohol drinking is reduced by a ₁-but not by a -opioid receptor antagonist in alcohol-preferring rats
pp. 7-13(7)
Authors: Honkanen A.; Vilamo L.; Wegelius K.; Sarviharju M.; Hyytia P.; Korpi E.R.

Effects of 5-HT_1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties
pp. 15-21(7)
Authors: Assie M.-B.; Koek W.

Inhibitors of Ca²⁺-dependent endopeptidases modulate morphine-induced effects in rats
pp. 23-27(5)
Authors: Lyupina Y.V.; Sudakov S.K.; Yarygin V.N.

Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus
pp. 29-35(7)
Authors: Miller A.S.; Walker J.M.

Tolbutamide blocks Ca²⁺- and voltage-dependent K⁺ currents of hippocampal Ca1 neurons
pp. 37-47(11)
Authors: Erdemli G.; Krnjevic K.

Antidepressant drugs given repeatedly change the binding of the dopamine D₂ receptor agonist, [³H]N-0437, to dopamine D₂ receptors in the rat brain
pp. 49-54(6)
Authors: Maj J.; Dziedzicka-Wasylewska M.; Rogoz R.; Rogoz Z.; Skuza G.

Cocaine increases circulating levels of atrial natriuretic peptide and pro atrial natriuretic peptide N-terminal fragment in conscious rats
pp. 55-62(8)
Authors: Pelkonen M.; Luodonpaa M.; Vuolteenaho O.; Pasanen M.; Ruskoaho H.

Intracisternally applied angiotensin II does not excite reticulospinal vasomotor neurons in anesthetized rats
pp. 63-71(9)
Authors: Miao-Kun S.; Reis D.J.

The positive inotropic effect of _1A-adrenoceptor stimulation is inhibited by 4-aminopyridine
pp. 73-80(8)
Authors: Williamson A.P.; Seifen E.; Lindemann J.P.; Kennedy R.H.

Comparison of the cardiovascular effects of two novel superoxide dismutase mimetics, SC-55858 and SC-54417, in conscious dogs
pp. 81-86(6)
Authors: Lowe D.; Pagel P.S.; McGough M.F.; Hettrick D.A.; Warltier D.C.

Influence of vascular tone on vasoconstrictor responses to the 5-HT₁-like receptor agonist sumatriptan in anaesthetised rabbits
pp. 87-92(6)
Authors: Choppin A.; O'Connor S.E.

Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from hemoglobin
pp. 93-98(6)
Authors: Mito K.; Fujii M.; Kuwahara M.; Matsumura N.; Shimizu T.; Sugano S.; Karaki H.

[Cys(O₂NH₂)²]enkephalin analogues and dalargin: selectivity for -opioid receptors
pp. 99-108(10)
Authors: Pencheva N.; Bocheva A.; Dimitrov E.; Ivancheva C.; Radomirov R.

Non-adrenergic non-cholinergic neuron stimulation in the cat lower esophageal sphincter
pp. 109-115(7)
Authors: Kortezova N.; Mizhorkova Z.; Milusheva E.; Varga G.; Vizi E.S.; Papasova M.

Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl^- secretion in dog tracheal epithelium
pp. 117-122(6)
Authors: Yu J.L.; Jackson D.M.; Blackham A.; Leff P.

Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea
pp. 123-128(6)
Authors: Gater P.R.; Wasserman M.A.; Renzetti L.M.

Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent
pp. 129-134(6)
Authors: Murakami N.; Ohta M.; Hashimoto K.; Kato K.; Mizota M.; Miwa I.; Okuda J.; Inoue G.; Kuzuya H.; Nakao K.; Imura H.

Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin
pp. 135-139(5)
Authors: Kahler C.M.; Bellmann R.; Reinisch N.; Schratzberger P.; Gruber B.; Wiedermann C.J.

Steroid inhibition of [³H]SR 95531 binding to the GABA_A recognition site
pp. 141-146(6)
Authors: Hawkinson J.E.; Acosta-Burruel M.; Kimbrough C.L.; Goodnough D.B.; Wood P.L.

Pharmacological profile of T-0632, a novel potent and selective CCK_A receptor antagonist, in vitro
pp. 147-154(8)
Authors: Taniguchi H.; Yazaki N.; Endo T.; Nagasaki M.

Affinity of various ligands for GABA_A receptors containing ₄₃₂, ₄₂, or ₁₃₂ subunits
pp. 155-162(8)
Authors: Scholze P.; Ebert V.; Sieghart W.

Blocking effects of promethazine, triprolidine and their analogues on the excitation caused by the peptide, achatin-I
pp. 163-171(9)
Authors: Salunga T.L.; Xiao Y.H.; Shu M.W.; Takeuchi H.; Matsunami K.-i.; Upton C.; Mercer A.D.

A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor
pp. 173-183(11)
Authors: Navajas C.; Kokkola T.; Poso A.; Honka N.; Gynther J.; Laitinen J.T.

Possible expression of a ₁ site in rat pheochromocytoma (PC12) cells
pp. 185-190(6)
Authors: Sagi N.; Yamamoto H.; Yamamoto T.; Okuyama S.; Moroji T.

Adenosine activates the K⁺ channel and enhances cytosolic Ca²⁺ release via a P_2Y purinoceptor in hippocampal neurons
pp. 191-199(9)
Authors: Ikeuchi Y.; Nishizaki T.; Mori M.; Okada Y.

Differential solubilization of rat liver ₁ and ₂ receptors: retention of ₂ sites in particulate fractions
pp. 201-210(10)
Authors: Torrence-Campbell C.; Bowen W.D.

Muscarinic receptors in developing rat colon
pp. 211-219(9)
Author: Zhang L.

[³H]2-(2-Benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I₂ receptors
pp. 221-229(9)
Authors: Lione L.A.; Nutt D.J.; Hudson A.L.

[³H]5-Hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT₄ receptor
pp. 231-235(5)
Authors: Adham N.; Gerald C.; Schechter L.; Vaysse P.; Weinshank R.; Branchek T.

Amiodarone affects membrane water permeability properties of human erythrocytes and rat mitochondria
pp. 237-241(5)
Authors: Federico A.; Battisti C.; Manneschi L.; Gaggelli E.; Tassini M.; Valensin G.; Vivi A.